切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2024, Vol. 18 ›› Issue (05) : 539 -543. doi: 10.3877/cma.j.issn.1674-3946.2024.05.019

论著

局部进展期直肠癌新辅助治疗后行ISR术远切缘距离的临床研究
高建新1, 王啸飞1, 于淼1, 路夷平1,()   
  1. 1. 100010 北京,首都医科大学附属北京中医医院肿瘤外科
  • 收稿日期:2023-11-09 出版日期:2024-10-26
  • 通信作者: 路夷平

A clinical study of ISR after neoadjuvant therapy for locally advanced rectal cancer

Jianxin Gao1, Xiaofei Wang1, Miao Yu1, Yiping Lu1,()   

  1. 1. Department of Oncology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China
  • Received:2023-11-09 Published:2024-10-26
  • Corresponding author: Yiping Lu
引用本文:

高建新, 王啸飞, 于淼, 路夷平. 局部进展期直肠癌新辅助治疗后行ISR术远切缘距离的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 539-543.

Jianxin Gao, Xiaofei Wang, Miao Yu, Yiping Lu. A clinical study of ISR after neoadjuvant therapy for locally advanced rectal cancer[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(05): 539-543.

目的

研究局部进展期直肠癌(LARC)新辅助治疗后行不同远切缘腹腔镜经括约肌间切除术(ISR)的临床效果,分析手术远切缘距离对不同病理TNM分期(ypTNM)患者预后的影响。

方法

回顾性分析2019年1月至2021年12月86例接受新辅助治疗的LARC患者临床资料,所有患者经新辅助治疗后均行腹腔镜ISR手术。根据术中远切缘距离分为远切缘<1 cm组(n=38例)和≥1 cm组(n=48例)。数据应用统计软件SPSS 23.0分析,不同手术远切缘组围手术期指标、肛门功能及生活质量用()表示,组间比较采用独立样本t检验;术后并发症用[例(%)]表示,组间比较采用Fisher精确概率或χ2检验;Kaplan-Meier法分析手术远切缘距离与不同病理分期亚组患者预后无病生存期(DFS)和总生存期(OS)的关系,Log-Rank检验生存差异。P<0.05为有统计学意义。

结果

两组患者围手术期相关指标、术后并发症、肛门功能、生活质量及术后OS生存差异均无统计学意义(P>0.05);远切缘≥1 cm组患者术后局部复发率及累积DFS生存优于<1 cm组(P<0.05);ypT1期和ypT2期患者术后DFS生存与远切缘距离无关(P>0.05);ypT3期远切缘<1 cm的患者DFS生存低于≥1 cm的患者(P<0.05)。

结论

局部进展期直肠癌新辅助治疗后ISR手术远切缘距离的选择不影响围手术期效果、并发症的发生、术后肛门功能恢复及生活质量;手术远切缘距离<1 cm与术后局部复发和DFS生存相关,尤对ypT3期患者的影响较为显著。

Objective

To investigate the clinical effect of laparoscopic transsphincterectomy (ISR) with different distal incisional margins after neoadjuvant therapy for locally advanced rectal cancer (LARC), and to analyze the influence of surgical distance on the prognosis of patients with different pathological TNM stages (ypTNM).

Methods

The clinical data of 86 LARC patients who received neoadjuvant therapy from January 2019 to December 2021 were retrospectively analyzed. All patients underwent laparoscopic ISR surgery after neoadjuvant therapy. According to the distance of distal incisal margin during operation, the patients were divided into the group <1 cm (n=38 cases) and the group ≥1 cm (n=48 cases). Statistical software SPSS 23.0 was used to analyze the data. Perioperative indexes, anal function and quality of life of different surgical resection margin groups were represented by (). Independent sample t test was used for comparison between groups. Postoperative complications were represented by [cases (%)], and Fisher exact probability or χ2 test was used for comparison between groups. Kaplan-Meier method was used to analyze the relationship between surgical resection margin distance and disease-free survival (DFS) and overall survival (OS) of patients in different pathological stage subgroups, and the survival difference was tested by Log-Rank. P<0.05 was considered statistically significant.

Results

There were no significant differences in perioperative parameters, postoperative complications, anal function, quality of life and OS survival between the two groups (P>0.05). The postoperative local recurrence rate and cumulative DFS survival in patients with distal resection margin ≥1 cm were better than those in <1 cm group (P<0.05). The postoperative DFS survival of ypT1 and ypT2 patients was not correlated with the distance of distal incisal margin (P>0.05). DFS survival in patients with distal resection margin <1 cm at ypT3 stage was lower than that in patients with distal resection margin ≥1 cm (P<0.05).

Conclusion

After neoadjuvant treatment for locally advanced rectal cancer, the selection of ISR resection margin did not affect perioperative results, the occurrence of complications, postoperative anal function recovery and quality of life. The distance of distal resection margin <1 cm is associated with postoperative local recurrence and DFS survival, especially in ypT3 patients.

表1 两组患者一般基线资料比较
表2 两组患者围手术期指标比较(
表3 两组患者术后并发症情况比较[例(%)]
表4 两组患者肛门功能Wexner评分及Williams分级比较
表5 两组患者EORTC QLQ-C30生活质量评分比较(
图1 两组患者术后DFS和OS生存情况
图2 ypT1期(A)、ypT2期(B)、ypT3期(C)不同远切缘距离患者术后DFS生存情况
[1]
杨盈赤,杨鋆,张忠涛. 中国腹腔镜直肠癌手术30年回顾与展望[J/CD]. 中华普外科手术学杂志(电子版)2021,15(01):6-9.
[2]
毛盛平,黄泽宇,李志刚,等. 局部进展期直肠癌新辅助治疗研究进展[J]. 临床肿瘤学杂志2023,28(02):172-177.
[3]
Koukourakis IMKouloulias VTiniakos D,et al. Current status of locally advanced rectal cancer therapy and future prospects[J]. Crit Rev Oncol Hematol2023,186:103992.
[4]
Özer İZengin Çaycı HM,et al. Distal spread and tumor regression patterns following preoperative chemoradiotherapy in rectal cancer patients[J]. Turk J Med Sci2021,51(6):2978-2985.
[5]
邵丽华,陈刚. 极限保肛之低位直肠癌经括约肌间切除术(ISR)[J]. 中国肿瘤外科杂志2021,13(02):105-108.
[6]
王晔,楼征,孟荣贵,等. 直肠癌新辅助治疗后肿瘤退缩模式及远切缘安全距离的研究进展[J]. 中华胃肠外科杂志2023,26(03):302-306.
[7]
朱汉建,高进,刘佳文,等. 应用腹腔镜改良ISR术行低位复杂性直肠肿瘤保肛术的一例报道[J/CD]. 中华普外科手术学杂志(电子版)2021,15(01):117-118.
[8]
邱小原,林国乐. 腹腔镜低位直肠癌保肛手术研究进展[J/CD]. 中华腔镜外科杂志(电子版)2021,14(02):65-69.
[9]
Weiser MR. AJCC 8th Edition: Colorectal Cancer[J]. Ann Surg Oncol2018,25(6):1454-1455.
[10]
国家卫生计生委医政医管局,中华医学会肿瘤学分会. 中国结直肠癌诊疗规范(2017年版)[J/CD]. 中华普通外科学文献(电子版)2018,12(03):145-159.
[11]
刘博,崔宏力. 直肠癌患者内括约肌切除术后肛门功能障碍的研究进展[J]. 中国医药2023,18(11):1756-1760.
[12]
石守森,杨阳,黄珂,等. 括约肌间切除术与人工肛门重建对低位直肠癌根治术患者术后生活质量的影响[J]. 中国现代普通外科进展2022,25(02):128-131.
[13]
Rodriguez-Pascual JNuñez-Alfonsel JIelpo B,et al. Watch-and-Wait policy versus robotic surgery for locally advanced rectal cancer: A cost-effectiveness study(RECCOSTE)[J]. Surg Oncol2022,41:101710.
[14]
Han JGWang ZJ. Evaluation strategy of complete response after neoadjuvant therapy for rectal cancer[J]. Zhonghua Wai Ke Za Zhi2023,61(9):738-743.
[15]
黄胜辉,高艺煌. 完整括约肌间纵肌切除术可能是减少经括约肌间切除术后局部复发的关键[J]. 结直肠肛门外科2022,28(05):491-492.
[16]
Song SHPark JSChoi GS,et al. Impact of the distal resection margin on local recurrence after neoadjuvant chemoradiation and rectal excision for locally advanced rectal cancer[J]. Sci Rep2021,11(1):22943.
[1] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[2] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[3] 吴晖, 佴永军, 施雪松, 魏晓为. 两种解剖入路下行直肠癌侧方淋巴结清扫的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 40-43.
[4] 周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[5] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[6] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[7] 庄宝雄, 邓海军. 单孔+1腹腔镜直肠癌侧方淋巴结清扫术[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 601-601.
[8] 郑民华, 蒋天宇, 赵轩, 马君俊. 中国腹腔镜直肠癌根治术30年发展历程与未来[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 591-595.
[9] 池畔, 黄胜辉. 中国腹腔镜直肠癌根治术30年来的巨大进步[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 596-600.
[10] 施一辉, 张平新, 朱勇, 杨德林. 机器人辅助前列腺根治术后切缘阳性的研究进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 633-637.
[11] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[12] 梁轩豪, 李小荣, 李亮, 林昌伟. 肠梗阻支架置入术联合新辅助化疗治疗结直肠癌急性肠梗阻的疗效及其预后的Meta 分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 472-482.
[13] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
[14] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[15] 郭曌蓉, 王歆光, 刘毅强, 何英剑, 王立泽, 杨飏, 汪星, 曹威, 谷重山, 范铁, 李金锋, 范照青. 不同亚型乳腺叶状肿瘤的临床病理特征及预后危险因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 524-532.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?